Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference
Carisma Therapeutics (Nasdaq: CARM), a clinical-stage biopharmaceutical company specializing in immunotherapies, announced its participation in the 7th Annual Evercore ISI HealthCONx Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Carisma Therapeutics (Nasdaq: CARM), a clinical-stage biopharmaceutical company specializing in immunotherapies, announced its participation in the 7th Annual Evercore ISI HealthCONx Conference. Steven Kelly, President and CEO, will engage in a fireside chat on December 5th at 9:35 am ET. The event will be accessible via audio webcast on the company's Investor Relations webpage under the Investor Events section, with -time archive availability.
Details
News Market Reaction – CARM
The recorded move for CARM in the trading session of this news was -1.06%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
An audio webcast of the event will be available on the Company's Investor Events section of the Investor Relations webpage and will be archived for a limited time following the event.
About Carisma
Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered in
Investors:
Shveta Dighe
Head of Investor Relations
investors@carismatx.com
Media Contact:
Julia Stern
(763) 350-5223
jstern@realchemistry.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/carisma-therapeutics-to-participate-in-the-7th-annual-evercore-isi-healthconx-conference-302316979.html
SOURCE Carisma Therapeutics Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.